In silico drug discovery made easy
We use Big Data and Artificial Intelligence to
accelerate your novel Drug Development through:
Our very easy to use SaaS platform provides a versatile set of applications to facilitate target identification and elucidate the mechanisms of action (MoA).
From in silico Drug Design to computational prediction of ADME and pharmacokinetics.
Elucidate the Mode of Action (MoA) of specific molecules and rationalize their off-target effects.
In silico screening of libraries, hit & lead expansion and drug repurposing.
Identify and characterize binding sites using Artificial Intelligence approaches.
Mind the Byte has started to implement changes in its organizational structure to improve resources efficiency after the acquisition of Intelligent Pharma almost a year ago. This new stage will conclude with the simplification of its organization, closing its Danish...
Mind the Byte and ZeClinics signed a strategic partnershipagreement to provide a pioneering integrated pack of in-silico and in-vivo services in preclinical drug discovery for pharmaceutical and biotech companies, compound library suppliers and research organizations....
We are happy to announce that Mind the Byte has released the new v2 version of our SaaS platform for computational drug discovery! In this new version you will find updated AI algorithms and databases, new technologies and an improvement of the User Experience (UX)....